CDH13 and breast cancer: RBBP8 has been identified as almost exclusively hypermethylated in BC (Mijnes et al., 2018), while Chen et al. showed CDH13 methylation as a biomarker with prognostic value for BC screening in urine samples (Ren et al., 2016).